-+ 0.00%
-+ 0.00%
-+ 0.00%

CAN FITE BIOPHARMA LTD - TO ADVANCE NAMODENOSON INTO PHASE 2B PANCREATIC CANCER STUDY WITH IMMUNOTHERAPY

Reuters·05/13/2026 11:00:03

Please log in to view news